Health Observance

Huntington’s disease: a rare cousin of Alzheimer’s

A snapshot to raise awareness
Chloe Kirk
May 14, 2023

Many of us have heard of the neurological disorder Alzheimer’s disease, which affects 1 in 9 over the age of 65. But fewer are familiar with a rarer form of dementia called Huntington’s disease which affects just 5.7 of every 100,000 people.

May is Huntington’s Disease Awareness Month, so let’s dive in a bit on what this disease is and where we are in treating it.

Discovery and diagnosis of Huntington’s

Huntington’s is an inherited neurological disorder that breaks down nerve cells involved in voluntary movement. The disease was first characterized by George Huntington in his 1872 paper detailing patients’ loss of motor control, jerky movements, personality changes, and cognitive decline. Huntington documented a hereditary pattern for the disease, but it wasn’t until 1983 when the Huntington gene (HTT) was molecular mapped to a human chromosome.

Gene regulation

HTT regulates neuronal and glial function in the brain, but an abnormal expansion of glutamine (polyQ) leads to Huntington’s. These abnormal HTT proteins form glue-y plaques in the brain — clumps of the protein with a specific Beta-sheet fold and difficult-to-dissolve (insoluble) structure.

Treating the plaques

Amyloid plaques are a characteristic among many neurological diseases (i.e. alpha-synuclein in Parkinson’s, amyloid-beta in Alzheimer’s). These diseases are difficult to treat due to their rigid and insoluble nature and the lack of tools able to disassemble these plaques in cells.

Current treatments of Huntington’s disease focus on limiting involuntary movements, but unfortunately this is preventative management and not a cure.

Recent drug approval for Alzheimer’s targets the amyloid plaque related to the disease, beta-amyloid, and many think similar approaches can be used for other amyloid plaque based diseases including Huntington’s.

Related stories

Huntingtin through a multiomic lens: A study shows that the mutant protein that causes Huntington’s disease can alter the binding properties of another protein, perhaps accounting for some of the mutation’s far-flung cellular effects.

A very delicate balance: Could blocking lysosomal gatekeeper PIKfyve slow neurodegeneration?

A family history of Alzheimer’s sparks interest in basic research: JBC Herbert Tabor Early Career Investigator Award winner Jenna Lentini shares her work at Discover BMB.

Overcoming missed connections to battle Alzheimer’s: Researchers identify a protein that may allow some people to resist dementia despite plaque accumulation.

Reimagining drugs for rare brain disorder: Researchers develop new pipeline to screen large number of existing compounds to find a therapy for an ataxia.

Neurodegenerative disease linked to microtubules: A team at McGill University reports a new role for sacsin, the protein mutated in a rare hereditary ataxia.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Chloe Kirk

Chloe Kirk is working toward her Ph.D. in biochemistry and molecular biology at the University of Miami. Her interests are science research, communication and outreach.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How bacteria inhibit gene expression
Journal News

How bacteria inhibit gene expression

Dec. 5, 2023

Researchers show how altering activity of the transcription factor CarD can cause downregulation and upregulation of some genes.

Where the heck did all those structures inside complex cells come from?
Feature

Where the heck did all those structures inside complex cells come from?

Dec. 3, 2023

Scientists agree that eons ago, a bacterium took up residence inside another cell and became its powerhouse, the mitochondrion. But there are competing theories about the birth of other organelles such as the nucleus and endoplasmic reticulum.

Untangling the genetics that underlie our facial features
Feature

Untangling the genetics that underlie our facial features

Dec. 2, 2023

After turning up hundreds of genes with hard-to-predict effects, some scientists are now probing the grander developmental processes that shape face geometry.

From the journals: JLR
Journal News

From the journals: JLR

Dec. 1, 2023

A safer combination therapy for liver disease. A mechanistic pathway of the pathophysiology of NASH. A novel therapeutic target for heart failure. Read about recent papers on these topics.

Insulin injections could one day be replaced with rock music
News

Insulin injections could one day be replaced with rock music

Nov. 26, 2023

Using mice, researchers engineered cells to release insulin in response to specific sound waves: the music of the band Queen.

From the journals: JBC
Journal News

From the journals: JBC

Nov. 24, 2023

Protein cleavage in polycystic kidney disease. Expanding tools to study ion channels. Mechanisms of 5-fluorouracil cytotoxicity and chemoresistance. Read about papers on these topics.